Centre d'urologie de Lille
Tarifs et remboursement
Conventionné secteur 2 avec OPTAM-CO
Carte Vitale acceptée
Tiers payant : Sécurité sociale
Moyens de paiement
Public reçu
Ce soignant ne permet pas la réservation en ligne pour les patients de moins de 18 ans
Expertises et actes
Carte et informations d'accès
Centre d'urologie de Lille
Moyens de transport
Métro - St Maurice Pellevoisin (ligne M2)Bus - Dieu De Marcq (ligne 50)
Bus - Ballon (ligne 50)
Informations pratiques
Rez-de-chausséeEntrée accessible
Parking gratuit
Présentation
Le Dr Pierre Colin vous accueille au sein du centre d'Urologie, à Lille et au sein des cabinets médicaux de la Bassée et de Lesquin. Le Dr Colin est spécialisé en chirurgie mini-invasive (chirurgie robotique, ultrasons focalisés) et en chirurgie de la statique pelvienne. Le Dr Pierre Colin ne réalise pas de chirurgie infantile.
Site web
Voir le siteDiplômes nationaux et universitaires
D.E.S. Chirurgie générale - Faculté de médecine Henri-Warembourg de Lille
Autres formations
Thèse de docteur en sciences (option cancérologie) - Université Lille Nord de France
D.E.S.C.Q. chirurgie urologique - Faculté de médecine Henri-Warembourg de Lille
Thèse de docteur en médecine - Faculté de médecine Henri-Warembourg de Lille
Master 2 de sciences chirurgicales - Université Paris 12 - Créteil
Expériences
Cabinet - Lille
Praticien - Hôpital Privé de La Louvière - Lille - Urologie
Praticien attaché - CH Seclin - Seclin - Urologie
Praticien hospitalier - CH Seclin - Seclin - Urologie
Chef de clinique en région - CHRU Lille/CH Seclin - Lille/Seclin - Urologie
Interne
Associations
Membre - Association Française d’Urologie (AFU)
Travaux et publications
Risk-adapted strategy for the kidney-sparing management of upper tract tumours - Seisen T, Colin P, Rouprêt M Nat Rev Urol
Follow-up of urothelial carcinoma: Review of the Cancer Committee of the French Association of Urology - Colin P, Neuzillet Y, Pignot G, Rouprêt M, Comperat E, Larré S, Roy C, Quintens H, Houedé N, Soulié M, Pfister C; les membres du Comité de cancérologie de l’Association française d’urologie. Prog Urol.
A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma - Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R, Compérat E, Mozer P, Cussenot O, Shariat SF, Rouprêt M. Eur Urol
Urothelial carcinomas of the upper tract: the myth became a reality - Rouprêt M, Colin P. Prog Urol.
Surgical treatment of upper tract urothelial carcinomas by nephroureterectomy: state of the art for the yearly scientific report of the French National Association of Urology - Neuzillet Y, Colin P, Phé V, Shariat SF, Rouprêt M Prog Urol.
Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies - Yakoubi R, Colin P, Seisen T, Léon P, Nison L, Bozzini G, Shariat SF, Rouprêt M Eur J Surg Oncol
Prognostic factors of upper tract urothelial carcinomas and impact on survival: a systematic review for the yearly scientific report of the French National Association of Urology - Colin P, Irani J, Drouin SJ, Shariat SF, Rouprêt M. Prog Urol.
Post-operative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localized and/or locally advanced upper tract urothelial carcinoma without metastasis. - Seisen T, Colin P, Hupertan V, Yates DR, Xylinas E, Nison L, Cussenot O, Neuzillet Y, Bensalah K, Novara G, Montorsi F, Zigeuner R, Remzi M, Shariat SF, Rouprêt M BJU Int.
Pathologic analysis of upper tract urothelial carcinomas: state of the art for the yearly scientific report of the French National Association of Urology - Varinot J, Colin P, Rouprêt M, Leroy X, Comperat E. Prog Urol.
Non-surgical treatment modalities available for the treatment of upper tract urothelial carcinomas: state-of-the-art for the yearly scientific report of the French National Association of Urology - Audenet F, Rouprêt M, Houédé N, Colin P. Prog Urol.
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy. - Hurel S, Rouprêt M, Seisen T, Comperat E, Phé V, Droupy S, Audenet F, Pignot G, Cathelineau X, Guy L, Cussenot O, Ouzzane A, Bozzini G, Nison L, Ruffion A, Colin P World J Urol.
Imaging of urothelial carcinomas of the upper tract: state of the art for the yearly scientific report of the National French Association of Urology - Puech P, Rouprêt M, Renard-Penna R, Lemaître L, Colin P. Prog Urol.
Epidemiology and risk factors of upper urinary tract tumors: literature review for the yearly scientific report of the French National Association of Urology - Ouzzane A, Rouprêt M, Leon P, Yates DR, Colin P. Prog Urol.
Conservative management of urothelial carcinomas of the upper tract: systematic review for the yearly scientific report of the French National Association of Urology - Pignot G, Colin P, Rouprêt M, Traxer O. Prog Urol.
Clinical, ureteroscopic and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art for the yearly scientific report of the French National Association of Urology - Nison L, Bozzini G, Rouprêt M, Traxer O, Colin P. Prog Urol.
Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art for the yearly scientific report of the French National Association of Urology - Seisen T, Cancel-Tassin G, Colin P, Cussenot O, Rouprêt M. Prog Urol.
Bladder cancer: Tumour recurrence after radical nephroureterectomy for UTUC - Ouzzane A, Colin P Nat Rev Urol.
The outbreak of focal therapy for localized prostate cancer management - Bozzini G, Colin P, Betrouni N, Ouzzane A, Puech P, Villers A. Rev Prat
The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy - Ouzzane A, Colin P, Ghoneim TP, Zerbib M, De La Taille A, Audenet F, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Maurin C, Nouhaud FX, Phe V, Polguer T, Roumiguié M, Ruffion A, Rouprêt M World J Urol
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy. - Colin P, Ghoneim TP, Nison L, Seisen T, Lechevallier E, Cathelineau X, Ouzzane A, Zerbib M, Long JA, Ruffion A, Crouzet S, Cussenot O, Audouin M, Irani J, Gardic S, Gres P, Audenet F, Roumiguié M, Valeri A, Rouprêt M World J Urol
Prognostic Value Of Microrna Expression Pattern In Upper Tract Urothelial Carcinoma - Izquierdo L, Ingelmo-Torres M, Mallofré C, Lozano JJ, Verhasselt-Crinquette M, Leroy X, Colin P, Comperat E, Roupret M, Alcaraz A, Mengual L. BJU Int
Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study. - Neuzillet Y, Soulie M, Larre S, Roupret M, Defortescu G, Murez T, Pignot G, Descazeaud A, Patard JJ, Bigot P, Salomon L, Colin P, Rigaud J, Bastide C, Durand X, Valeri A, Kleinclauss F, Bruyere F, Pfister C BJU Int.
Malnourishment in bladder cancer and the role for immunonutrition at the time of cystectomy: an overview for urologists - Munbauhal G, Drouin SJ, Mozer P, Colin P, Phé V, Cussenot O, Rouprêt M. BJU Int.
Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. - Pignot G, Colin P, Zerbib M, Audenet F, Soulié M, Hurel S, Delage F, Irani J, Descazeaud A, Droupy S, Rozet F, Phé V, Ruffion A, Long JA, Crouzet S, Houlgatte A, Bigot P, Guy L, Faïs PO, Rouprêt M Urol Oncol
Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma - Masson-Lecomte A, Colin P, Bozzini G, Nison L, de La Taille A, Comperat E, Zerbib M, Rozet F, Cathelineau X, Valeri A, Ruffion A, Guy L, Droupy S, Cussenot O, Rouprêt M. World J Urol.
Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy - Hurel S, Rouprêt M, Ouzzane A, Rozet F, Xylinas E, Zerbib M, Berod AA, Ruffion A, Adam E, Cussenot O, Houlgatte A, Phé V, Nouhaud FX, Bensadoun H, Delage F, Guillotreau J, Guy L, Karsenty G, De La Taille A, Colin P BJU Int.
Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours. - Hollande C, Colin P, de La Motte Rouge T, Audenet F, Yates DR, Phé V, Ouzzane A, Droupy S, Ruffion A, de La Taille A, Guy L, Cussenot O, Rozet F, Xylinas E, Zerbib M, Spano JP, Khayat D, Bitker MO, Rouprêt M BJU Int
Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model. - Bozzini G, Colin P, Betrouni N, Maurage CA, Leroy X, Simonin S, Martin-Schmitt C, Villers A, Mordon S Photodiagnosis Photodyn Ther
CCAFU Recommendations 2013: Upper urinary tract carcinoma - Pfister C, Roupret M, Neuzillet Y, Larré S, Pignot G, Quintens H, Houedé N, Compérat E, Colin P, Roy C, Davin JL, Guy L, Irani J, Lebret T, Coloby P, Soulié M; Les membres du CCAFU. Prog Urol
CCAFU Recommendations 2013: Bladder carcinoma - Pfister C, Roupret M, Neuzillet Y, Larré S, Pignot G, Quintens H, Houedé N, Compérat E, Colin P, Roy C, Davin JL, Guy L, Irani J, Lebret T, Coloby P, Soulié M; Les membres du CCAFU. Prog Urol
An image guided treatment platform for prostate cancer photodynamic therapy. - Betrouni N, Colin P, Puech P, Villers A, Mordon S. Conf Proc IEEE Eng Med Biol Soc.
An anatomically realistic and adaptable prostate phantom for laser thermotherapy treatment planning - Betrouni N, Nevoux P, Leroux B, Colin P, Puech P, Mordon S. Med Phys.
A New Proposal to Risk Stratify Urothelial Carcinomas of the Upper Urinary Tract (UTUCs) in a Predefinitive Treatment Setting: Low-risk Versus High-risk UTUCs - Rouprêt M, Colin P, Yates DR. Eur Urol.
Urothelial carcinomas of the upper urinary tract are now recognised as a true and distinct entity from bladder cancer and belong fully to the broad spectrum of onco-urologic neoplasm - Rouprêt M, Colin P World J Urol
The role of ASA scores in predicting UUT-UC outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study - Arvin-Berod A, Colin P, Yates DR, Ouzzane A, Audouin M, Adam E, Arroua F, Marchand M, Bigot P, Soulié M, Roumiguié M, Polguer T, Gardic S, Grès P, Ravier E, Neuzillet Y, Delage F, Bodin T, Pignot G, Rouprêt M BJU Int
The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database - Nison L, Rouprêt M, Bozzini G, Ouzzane A, Audenet F, Pignot G, Ruffion A, Cornu JN, Hurel S, Valeri A, Roumiguie M, Polguer T, Hoarau N, Mérigot de Treigny O, Xylinas E, Matte A, Droupy S, Fais PO, Descazeaud A, Colin P World J Urol
Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI - Sufana Iancu A, Colin P, Puech P, Villers A, Ouzzane A, Fantoni JC, Leroy X, Lemaitre L World J Urol
Rôle pronostique des emboles vasculaires tumoraux dans les tumeurs de la voies excrétrices urinaires supérieures: analyse rétrospective monocentrique - Colin P, Verhasselt-Crinquette M, Ouzzane A, Yakoubi R, Bouchery C, Debrock S, A Villers, Leroy X Prog Urol.
Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized post-operative nomogram using decision curve analysis. - Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, et al. J Urol
Photodynamic Therapy in urology: what can we do now and where are we heading? - Bozzini G, Colin P, Betrouni N, Nevoux P, Ouzzane A, Puech P, Villers A, Mordon S Photodiagnosis Photodyn. Ther.,
Oncologic Outcomes and Survival in pT0 Tumors After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results from of a Large Multicenter International Collaborative Study - Rouprêt M, Xylinas E, Colin P, Kluth L, Karakiewicz P, Shariat SF Eur Urol
Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. - Xylinas E, Colin P, Audenet F, Phe V, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Polguer T, Ruffion A, Valeri A, Rozet F, Long JA, Zerbib M, Rouprêt M. World J Urol
Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort - Bozzini G, Nison L, Colin P, Ouzzane A, Yates DR, Audenet F, Pignot G, Arvin-Berod A, Merigot O, Guy L, Irani J, Saint F, Gardic S, Gres P, Rozet F, Neuzillet Y, Ruffion A, Roupret M World J Urol
Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival - Colin P, Ouzzane A, Yates DR, Audenet F, Pignot G, Arvin-Berod A, Merigot de Treigny O, Valeri A, Irani J, Saint F, Gardic S, Gres P, Rozet F, Neuzillet Y, Ruffion A, Rouprêt M Ann Surg Oncol
Focal therapy of prostate cancer: Energies and procedures - Bozzini G, Colin P, Nevoux P, Villers A, Mordon S, Betrouni N Urol Oncol
Focal Laser Ablation of Prostate Cancer: Definition, Needs and Future - Colin P, Mordon S, Nevoux P, Marqa MF, Ouzzane A, Puech P, Bozzini G, Leroux B,Villers A, Betrouni N Adv Urol.
Elastic image registration for guiding focal laser ablation of prostate cancer: Preliminary results - Makni N, Puech P, Colin P, Azzouzi A, Mordon S, Betrouni N Comput. Methods Programs Biomed
Conservative Management of Upper Tract Urothelial Carcinoma in France: A 2004-2011 National Practice Report - Colin P, Rouprêt M, Ghoneim TP, Traxer O, Zerbib M, Xylinas E Eur Urol
Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. - Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M BJU Int
Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram - Yates DR, Hupertan V, Colin P, Ouzzane A, Descazeaud A, Long JA, Pignot G, Crouzet S, Rozet F, Neuzillet Y, Soulie M, Bodin T, Valeri A, Cussenot O, Rouprêt M Br J Cancer
Assessment of Human Epidermal Growth Factor Receptor 2 status in urothelial carcinoma of the upper urinary tract. A study using dual-colour in-situ hybridization and immunohistochemistry - Verhasselt-Crinquette M, Colin P, Ouzzane A, Gnemmi V, Robin YM, Aubert S, Villers A, Leroy X Applied Immunohistochemistry & Molecular Morphology
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool - Audenet F, Colin P, Yates DR, Ouzzane A, Pignot G, Long JA, Soulie M, Phé V, Bensadoun H, Guy L, Ruffion A, Valeri A, Cormier L, Droupy S, De La Taille A, Saint F, Faïs PO, Houlgatte A, Cussenot O, Rouprêt M BJU Int
Horaires et coordonnées
Horaires d'ouverture
Contact d'urgence
Coordonnées
Numéro de téléphone :
Numéro de fax :
Tarifs
- Consultation CS + MCS + MPC30 € à 50 €
- Consultation APC55 € à 75 €
- Urgences 30 € à 75 €
Ces honoraires vous sont communiqués à titre indicatif par le soignant. Ils peuvent varier selon le type de soins finalement réalisés en cabinet, le nombre de consultations et les actes additionnels nécessaires. En cas de dépassement des tarifs, le soignant doit en avertir préalablement le patient.
Informations légales
Numéro RPPS
10100181733